Inge Vliegen

1.8k total citations
33 papers, 1.4k citations indexed

About

Inge Vliegen is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Inge Vliegen has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 17 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Inge Vliegen's work include Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis B Virus Studies (8 papers). Inge Vliegen is often cited by papers focused on Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis B Virus Studies (8 papers). Inge Vliegen collaborates with scholars based in Belgium, Netherlands and United States. Inge Vliegen's co-authors include Johan Neyts, Erik De Clercq, Jan Paeshuyse, Armando M. De Palma, Frank Stassen, Cathrien A. Bruggeman, Lotte Coelmont, Gert Grauls, Leen Delang and Raghunath Singha and has published in prestigious journals such as Circulation, PLoS ONE and Hepatology.

In The Last Decade

Inge Vliegen

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Vliegen Belgium 19 592 408 341 278 251 33 1.4k
Marc P. Windisch South Korea 21 574 1.0× 565 1.4× 502 1.5× 410 1.5× 113 0.5× 57 1.6k
Seungtaek Kim South Korea 24 586 1.0× 494 1.2× 677 2.0× 957 3.4× 193 0.8× 75 2.4k
M. A. Brothers United States 9 332 0.6× 252 0.6× 327 1.0× 259 0.9× 62 0.2× 12 1.0k
Joseph M. Colacino United States 24 794 1.3× 340 0.8× 730 2.1× 618 2.2× 191 0.8× 67 2.0k
Che C. Colpitts Canada 20 565 1.0× 446 1.1× 556 1.6× 227 0.8× 39 0.2× 43 1.6k
Kai Lin United States 25 919 1.6× 1.0k 2.5× 579 1.7× 588 2.1× 78 0.3× 50 2.0k
Frank J. Dutko United States 23 1.1k 1.9× 281 0.7× 619 1.8× 807 2.9× 281 1.1× 43 2.9k
Leda Bassit United States 24 916 1.5× 808 2.0× 446 1.3× 758 2.7× 114 0.5× 87 1.9k
Takeshi Noshi Japan 12 851 1.4× 126 0.3× 242 0.7× 325 1.2× 41 0.2× 24 1.1k
Anita Y. M. Howe United States 20 654 1.1× 709 1.7× 178 0.5× 542 1.9× 94 0.4× 29 1.3k

Countries citing papers authored by Inge Vliegen

Since Specialization
Citations

This map shows the geographic impact of Inge Vliegen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Vliegen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Vliegen more than expected).

Fields of papers citing papers by Inge Vliegen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Vliegen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Vliegen. The network helps show where Inge Vliegen may publish in the future.

Co-authorship network of co-authors of Inge Vliegen

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Vliegen. A scholar is included among the top collaborators of Inge Vliegen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Vliegen. Inge Vliegen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delang, Leen, Johan Neyts, Inge Vliegen, et al.. (2013). Hepatitis C Virus-Specific Directly Acting Antiviral Drugs. Current topics in microbiology and immunology. 369. 289–320. 31 indexed citations
2.
Vliegen, Inge, Leen Delang, & Johan Neyts. (2013). Selecting and Characterizing Drug-Resistant Hepatitis C Virus Replicon. Methods in molecular biology. 1030. 93–103. 3 indexed citations
3.
Tsay, Shwu‐Chen, Jih Ru Hwu, Raghunath Singha, et al.. (2013). Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus. European Journal of Medicinal Chemistry. 63. 290–298. 64 indexed citations
4.
Vliegen, Inge, Guang Yang, Dennis E. Hruby, Robert Jordan, & Johan Neyts. (2011). Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge. Antiviral Research. 93(1). 160–166. 20 indexed citations
5.
Delang, Leen, Inge Vliegen, Pieter Leyssen, & Johan Neyts. (2011). In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitors. Journal of Hepatology. 56(1). 41–48. 13 indexed citations
6.
Coelmont, Lotte, Xavier Hanoulle, Udayan Chatterji, et al.. (2010). DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A. PLoS ONE. 5(10). e13687–e13687. 143 indexed citations
7.
Coelmont, Lotte, Philippe Gallay, Michael Bobardt, et al.. (2009). 88 PARTICULAR IN VITRO ANTI-HCV ACTIVITIES AND RESISTANCE PROFILE OF THE CYCLOPHILIN INHIBITOR DEBIO 025. Journal of Hepatology. 50. S36–S36. 10 indexed citations
8.
Palma, Armando M. De, Inge Vliegen, Erik De Clercq, & Johan Neyts. (2008). Selective inhibitors of picornavirus replication. Medicinal Research Reviews. 28(6). 823–884. 199 indexed citations
9.
Vliegen, Inge, Jan Paeshuyse, Eric Mabery, et al.. (2007). GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants. 8 indexed citations
10.
Vliegen, Inge, Jan Paeshuyse, Laura S. Lehman, et al.. (2007). Substituted Imidazopyridines as Potent Inhibitors of Hepatitis C Virus Replication that Target the Viral Polymerase. Antiviral Research. 74(3). A37–A37. 2 indexed citations
11.
Hwu, Jih Ru, Raghunath Singha, Yung Chang, et al.. (2007). Synthesis of new benzimidazole–coumarin conjugates as anti-hepatitis C virus agents. Antiviral Research. 77(2). 157–162. 178 indexed citations
12.
Coelmont, Lotte, Jan Paeshuyse, Suzanne J. F. Kaptein, et al.. (2007). The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile. Antiviral Research. 74(3). A39–A39. 9 indexed citations
13.
Paeshuyse, Jan, Lotte Coelmont, Inge Vliegen, et al.. (2006). Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin. Biochemical and Biophysical Research Communications. 348(1). 139–144. 57 indexed citations
14.
Stassen, Frank, et al.. (2006). Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease?. Journal of Clinical Virology. 35(3). 349–353. 62 indexed citations
15.
Vliegen, Inge, Jan Jacobs, Erik Beuken, Cathrien A. Bruggeman, & Cornelis Vink. (2005). Rapid identification of bacteria by real-time amplification and sequencing of the 16S rRNA gene. Journal of Microbiological Methods. 66(1). 156–164. 18 indexed citations
16.
Vliegen, Inge, Adrian M. Duijvestijn, Frank Stassen, & Cathrien A. Bruggeman. (2004). Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis. Microbes and Infection. 6(12). 1056–1062. 32 indexed citations
17.
Vliegen, Inge, A. M. Duijvestijn, Gert Grauls, et al.. (2003). Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes and Infection. 6(1). 17–24. 58 indexed citations
18.
Vliegen, Inge, Selma B. Herngreen, Gert Grauls, Cathrien A. Bruggeman, & Frank Stassen. (2003). Improved detection and quantification of mouse cytomegalovirus by real-time PCR. Virus Research. 98(1). 17–25. 25 indexed citations
19.
Kurvers, H. A. J. M., et al.. (2002). Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovascular Research. 56(2). 269–276. 44 indexed citations
20.
Vliegen, Inge, Gert Grauls, André van der Ven, et al.. (2000). Cytomegalovirus (CMV) infection accelerates the development of atherosclerosis in apolipoproteinE (apoE) knock-out mice. Circulation. 102.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc P. Windisch Breakdown of academic impact, for papers by Seungtaek Kim Breakdown of academic impact, for papers by M. A. Brothers Breakdown of academic impact, for papers by Joseph M. Colacino Breakdown of academic impact, for papers by Che C. Colpitts Breakdown of academic impact, for papers by Kai Lin Breakdown of academic impact, for papers by Frank J. Dutko Breakdown of academic impact, for papers by Leda Bassit Breakdown of academic impact, for papers by Takeshi Noshi Breakdown of academic impact, for papers by Anita Y. M. Howe
Rankless by CCL
2026